{"gene":"LIMK1","run_date":"2026-06-10T02:59:49","timeline":{"discoveries":[{"year":1995,"finding":"LIMK1 (murine Limk1) encodes a protein kinase that autophosphorylates on serine, tyrosine, and threonine residues in vitro; mutation of residue D460 within the IHRDL catalytic motif abolishes kinase activity, establishing this residue as essential for catalysis.","method":"In vitro kinase assay with GST-Limk1 fusion protein; active-site mutagenesis (D460A)","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct in vitro reconstitution of autophosphorylation plus mutagenesis of catalytic residue in a single focused study","pmids":["7478547"],"is_preprint":false},{"year":1995,"finding":"LIMK1 (rat LIMK-1) phosphorylates serine and threonine residues of myelin basic protein in vitro, confirming serine/threonine kinase substrate activity.","method":"In vitro kinase assay with immunoprecipitated LIMK-1 and MBP as substrate","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — single lab, single in vitro assay on a non-physiological substrate","pmids":["7651734"],"is_preprint":false},{"year":2002,"finding":"LIMK-1 knockout mice show reduced cofilin phosphorylation in vivo, abnormal dendritic spine morphology, enhanced hippocampal LTP, and deficits in spatial learning and fear responses, establishing LIMK-1 as an in vivo regulator of cofilin, spine morphogenesis, and synaptic function.","method":"LIMK-1 gene knockout mouse model; electrophysiology (LTP); behavioral tests (Morris water maze, fear conditioning); immunoblotting for p-cofilin","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean KO with multiple orthogonal readouts (biochemical, electrophysiological, behavioral), widely replicated","pmids":["12123613"],"is_preprint":false},{"year":2003,"finding":"LIMK1 physically binds the tail domain of BMPR-II (identified by yeast two-hybrid); this interaction inhibits LIMK1's ability to phosphorylate cofilin; addition of BMP4 ligand relieves this inhibition; a BMPR-II mutant with the smallest PPH-associated C-terminal truncation fails to bind or inhibit LIMK1.","method":"Yeast two-hybrid screen; co-immunoprecipitation; in vitro cofilin phosphorylation assay; truncation mutant analysis","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — binding confirmed by Co-IP, functional consequence shown by in vitro kinase assay, mutant controls included in single rigorous study","pmids":["12963706"],"is_preprint":false},{"year":2003,"finding":"Fluid shear stress activates the Rho–ROCK–LIMK–cofilin pathway in vascular endothelial cells; dominant-negative forms of RhoA, ROCK, LIMK, and cofilin each block shear-stress-induced SREBP activation, placing LIMK downstream of ROCK and upstream of cofilin in this mechanosensing cascade.","method":"Dominant-negative mutant expression; reporter assays for SREBP activity; epistasis analysis in endothelial cells","journal":"Circulation research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis with multiple dominant negatives, single lab, pathway ordering established","pmids":["12775580"],"is_preprint":false},{"year":2004,"finding":"LIMK1 is enriched in the Golgi apparatus (requiring its LIM domain for Golgi localization) and at growth cones (requiring its PDZ domain) in neurons. Overexpression of wild-type LIMK1 suppresses trans-Golgi tubule formation and prevents Golgi fragmentation; kinase-dead LIMK1 has opposite effects. LIMK1 accelerates axon formation and regulates Golgi-derived vesicle traffic in a cofilin-phosphorylation-dependent manner.","method":"Confocal microscopy; subcellular fractionation; expression of epitope-tagged wild-type and kinase-dead LIMK1; constitutively active cofilin rescue","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 2 / Moderate — direct localization with functional consequence established by multiple constructs and rescue experiments in one study","pmids":["15090620"],"is_preprint":false},{"year":2004,"finding":"LATS1 tumor suppressor binds LIMK1 in vitro and in vivo, co-localizes with LIMK1 at the actomyosin contractile ring during cytokinesis, and inhibits LIMK1-mediated cofilin phosphorylation; loss of LATS1 increases multinucleate cells, establishing LATS1 as a negative regulator of LIMK1 during cytokinesis.","method":"GST pull-down (in vitro binding); co-immunoprecipitation; immunofluorescence co-localization; antibody microinjection; siRNA knockdown; LATS1 knockout mice","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — in vitro binding confirmed by GST pull-down and Co-IP, functional inhibition demonstrated, genetic loss-of-function (KO mice + siRNA + antibody microinjection) with clear cytokinesis phenotype","pmids":["15220930"],"is_preprint":false},{"year":2004,"finding":"LIMK1 binds BMPR-II in neurite tips; this interaction is required for BMP7-dependent induction of dendritic arbor in cortical neurons. The physical interaction of LIMK1 with BMPR-II synergizes with Cdc42 to activate LIMK1 catalytic activity, defining a Smad-independent BMP pathway that links the BMP receptor to actin dynamics during dendritogenesis.","method":"Co-immunoprecipitation; confocal colocalization; dominant-negative and kinase-dead constructs; cortical neuron dendrite morphology assays","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP, functional rescue, and activity assays in a single focused study establishing mechanistic pathway","pmids":["15538389"],"is_preprint":false},{"year":2004,"finding":"B-Raf maintains actin stress fibers in fibroblasts via a ROCKII/LIMK/cofilin pathway; B-raf−/− MEFs show reduced ROCKII expression, reduced cofilin phosphorylation, and reduced F-actin; these defects are restored by overexpression of LIMK, placing LIMK downstream of ROCKII in the B-Raf pathway.","method":"B-raf knockout mouse embryonic fibroblasts; LIMK overexpression rescue; immunoblotting for p-cofilin; F-actin staining","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KO cells with defined molecular phenotype and LIMK overexpression rescue, single lab","pmids":["15199148"],"is_preprint":false},{"year":2005,"finding":"Alpha2-macroglobulin (alpha2M*) binding to GRP78 on prostate cancer cells activates PAK-2 (not PAK-1), which in turn phosphorylates LIMK; silencing PAK-2 gene expression greatly attenuates LIMK phosphorylation, placing PAK-2 upstream of LIMK in this signaling cascade.","method":"siRNA gene silencing; co-immunoprecipitation; in vitro kinase assay; immunoblotting for p-LIMK and p-cofilin","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — siRNA epistasis plus co-IP and kinase assay, single lab","pmids":["15908432"],"is_preprint":false},{"year":2006,"finding":"LIMK1 localizes to cell–cell adhesion sites in interphase, redistributes to spindle poles during prometaphase through anaphase, and accumulates at the cleavage furrow in telophase, indicating cell-cycle-dependent spatial regulation distinct from LIMK2.","method":"Immunofluorescence analysis throughout the cell cycle; nocodazole synchronization","journal":"Experimental cell research","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — direct localization by immunofluorescence across multiple cell-cycle stages, single lab, no functional manipulation of LIMK1 localization","pmids":["16455074"],"is_preprint":false},{"year":2008,"finding":"In prostate cancer cells, PAK4 binds LIMK1 and phosphorylates it in an HGF-dependent manner; this interaction is concentrated in peripheral foci detected by FRET-FLIM; PAK4 and LIMK1 act synergistically to increase cell migration speed via cofilin phosphorylation.","method":"Co-immunoprecipitation; in vitro phosphorylation assay; FRET-FLIM for direct intracellular interaction; siRNA knockdown; migration assays","journal":"Cellular signalling","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — direct interaction confirmed by Co-IP and independently by FRET-FLIM in living cells, functional consequence by siRNA, multiple orthogonal methods","pmids":["18424072"],"is_preprint":false},{"year":2009,"finding":"PKA directly phosphorylates Limk1, enhancing its activity and the downstream phosphorylation of cofilin; this occurs downstream of Prkar1a loss without Rho or Rac activation, defining a Rho-independent PKA→Limk1→cofilin axis that controls cell morphology and migration.","method":"Prkar1a−/− MEFs; PKA activation by pharmacological agents; in vitro phosphorylation of Limk1 by PKA; immunoblotting; epistasis with Rho/Rac inhibitors","journal":"EMBO reports","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct in vitro phosphorylation of Limk1 by PKA plus genetic (KO MEF) and pharmacological epistasis, single lab with multiple methods","pmids":["19424295"],"is_preprint":false},{"year":2012,"finding":"LIMK1 physically interacts with TrkB; BDNF-induced TrkB dimerization leads to LIMK1 dimerization and transphosphorylation independent of TrkB kinase activity, activating LIMK1 which then phosphorylates cofilin and promotes actin polymerization and axonal elongation.","method":"Co-immunoprecipitation; dominant-negative TrkB constructs; cofilin phosphorylation assay; membrane fractionation; axonal elongation assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP, mechanistic mutant controls, functional readout, single lab","pmids":["23086941"],"is_preprint":false},{"year":2012,"finding":"Rho promotes a complex between fascin-1 and LIMK1/LIMK2 downstream of Rho kinase; this complex regulates filopodia stability and the interaction of fascin-1 with actin, as detected by FRET-FLIM.","method":"Co-immunoprecipitation; FRET-FLIM (fascin-1/actin interaction); Rho kinase inhibition; dominant-negative constructs","journal":"BMC biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP confirmed interaction, FRET-FLIM provides functional readout in intact cells, single lab","pmids":["22883572"],"is_preprint":false},{"year":2012,"finding":"Non-canonical BMPRII signaling through the LIMK/cofilin pathway mediates cadherin-6B-induced de-epithelialization during neural crest EMT; dominant-negative LIMK1 reduces de-epithelialization by cadherin-6B or BMP, and a phosphorylation-deficient cofilin mutant (S3A) inhibits de-epithelialization, placing LIMK1 and cofilin downstream of BMPRII in this process.","method":"Dominant-negative and wild-type LIMK1 overexpression in Xenopus neural tube; cofilin S3A mutant; in vivo delamination assay","journal":"Developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis with multiple dominant-negative and mutant constructs in vivo (Xenopus), single lab","pmids":["22537493"],"is_preprint":false},{"year":2013,"finding":"DAPK functions as a scaffold protein for the LIMK/cofilin complex in TNF-induced apoptosis; TNF treatment enhances phosphorylation of LIMK at Thr508 and cofilin at Ser3; modulation of DAPK activity (inhibitor, siRNA, overexpression) correspondingly alters both phosphorylations; TNF triggers redistribution of LIMK, DAPK, and cofilin to the perinuclear compartment.","method":"Peptide array screen; siRNA knockdown; DAPK inhibitor; overexpression; immunofluorescence; immunoblotting; structural modeling","journal":"The international journal of biochemistry & cell biology","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — multiple perturbation approaches (siRNA, inhibitor, OE) with phosphorylation readouts, single lab, structural model is computational","pmids":["23702034"],"is_preprint":false},{"year":2014,"finding":"LIMK1 interacts with adaptor LRAP25; the LRAP25-MRCK complex localizes to the lamellipodium and is required for local LIMK1 activation and cofilin phosphorylation; inhibition of MRCK or LRAP25 suppresses LIMK1 activity and disrupts lamellipodial F-actin, cell polarization, and motility.","method":"Co-immunoprecipitation; MRCK and LRAP25 siRNA knockdown; cofilin phosphorylation immunoblotting; F-actin imaging; cell migration assays","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP, siRNA epistasis with functional readout, single lab","pmids":["25107909"],"is_preprint":false},{"year":2015,"finding":"LIMK1 interacts with and regulates the transcription factor CREB; LIMK1-KO mice are defective in late-phase LTP (L-LTP) and long-term memory (LTM) but not short-term memory; both L-LTP and LTM deficits are rescued by increasing CREB activity, identifying a LIMK1→CREB axis for LTM.","method":"LIMK1 knockout mice; co-immunoprecipitation (LIMK1-CREB interaction); electrophysiology (L-LTP); behavioral tests (LTM vs STM); CREB activator rescue","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — KO mice with clean phenotype, Co-IP for interaction, rescue experiment, multiple orthogonal methods","pmids":["25645926"],"is_preprint":false},{"year":2015,"finding":"PAK6 binds LIMK1 and phosphorylates it at Thr-508, activating LIMK1 which then phosphorylates cofilin; PAK6 and LIMK1 co-localize in the cytoplasm; this PAK6→LIMK1→cofilin axis controls stress fiber formation and actin dynamics required for prostate cancer cell invasion.","method":"Co-immunoprecipitation; in vitro phosphorylation (PAK6→LIMK1 at Thr-508); cofilin phosphorylation immunoblotting; immunofluorescence co-localization; migration/invasion assays","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 1–2 / Moderate — Co-IP plus direct phosphorylation assay identifying specific residue, single lab","pmids":["25714010"],"is_preprint":false},{"year":2016,"finding":"LIMK1 phosphorylates tyrosine Y573 in the cytoplasmic domain of MT1-MMP, a novel non-cofilin substrate; this phosphorylation regulates cortactin association with MT1-MMP-positive endosomes and invadopodia formation, thereby controlling matrix degradation and cell invasion.","method":"Co-immunoprecipitation; in vitro kinase assay identifying Y573 phosphorylation; site-directed mutagenesis of Y573; cortactin association assay; invadopodia/matrix degradation assays; siRNA knockdown of LIMK1/2","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct in vitro phosphorylation of a novel substrate at a defined residue, mutagenesis, functional consequence established, single lab with multiple orthogonal methods","pmids":["27116935"],"is_preprint":false},{"year":2016,"finding":"Neuroligin-1 C-terminal domain interacts with spine-associated Rap GTPase-activating protein (SPAR) and activates LIMK1/cofilin-mediated actin reorganization to enhance spine and synapse number and modulate synaptic plasticity.","method":"Co-immunoprecipitation; dominant-negative and overexpression constructs; cofilin phosphorylation assay; spine morphology and synapse density quantification; electrophysiology","journal":"The Journal of cell biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP, functional constructs, multiple cellular readouts, single lab","pmids":["26880202"],"is_preprint":false},{"year":2019,"finding":"ROCK2 (not ROCK1) promotes dendritic spine loss via LIMK1; ROCK2-LIMK1 pathway mediates Aβ42 oligomer-induced spine degeneration and neuronal hyperexcitability; pharmacological inhibition of LIMK1 renders dendritic spines resilient to Aβ42 and rescues spine loss in hAPP mice.","method":"Primary hippocampal neuron cultures; ROCK1/ROCK2 overexpression; LIMK1 pharmacological inhibition; live-cell microscopy; multielectrode array; hAPP mouse model with LIMK1 inhibitor treatment","journal":"Science signaling","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal approaches (cell culture, live imaging, MEA, in vivo mouse model), dissection of ROCK1 vs ROCK2 specificity, single lab with extensive validation","pmids":["31239325"],"is_preprint":false},{"year":2019,"finding":"Nischarin mutation (L972P) in edison mice activates PAK1, RAC1, and downstream LIMK1 and NF-κB signaling in middle ear epithelia, contributing to chronic otitis media, establishing LIMK1 as part of the Nischarin/PAK1/RAC1 pathway in middle ear inflammation.","method":"N-ethyl-N-nitrosourea mutagenesis mouse model; genetic interaction analysis (Nisch × Itga5); signaling pathway analysis in middle ear epithelia; immunoblotting","journal":"PLoS genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic mouse model with defined mutation and pathway analysis, but LIMK1 placement is correlative within the pathway in the middle ear context","pmids":["28806779"],"is_preprint":false},{"year":2019,"finding":"ROCK1 (not LIMK1 or PAK2) is the key non-redundant regulator of apoptotic membrane blebbing and apoptotic body formation; CRISPR/Cas9 deletion of LIMK1 does not impair apoptotic blebbing, demonstrating that LIMK1 is dispensable for this process.","method":"CRISPR/Cas9 knockout of LIMK1, ROCK1, PAK2; pharmacological inhibition; apoptotic blebbing quantification; apoptotic body formation assay","journal":"Cell death and differentiation","confidence":"High","confidence_rationale":"Tier 2 / Moderate — clean CRISPR KO with clear negative result for LIMK1, rigorous comparison with ROCK1 and PAK2 KOs","pmids":["31043701"],"is_preprint":false},{"year":2019,"finding":"X-ray crystal structures of the LIMK1 kinase domain reveal a unique 'rock-and-poke' catalytic mechanism, the basis of substrate specificity, and regulation by activation loop phosphorylation; crystal structures with inhibitors PF-477736 and staurosporine provide insight into LIMK1 plasticity upon ligand binding.","method":"X-ray crystallography; RapidFire mass spectrometry activity assay; differential scanning fluorimetry; mutagenesis","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1 / Strong — high-resolution crystal structures with functional validation by activity assays; multiple structures in one rigorous study","pmids":["31652302"],"is_preprint":false},{"year":2009,"finding":"LIMK1 acts downstream of BMPR-II in extending retinal ganglion cell (RGC) axons: expression of a BMPRII lacking the LIMK1-binding domain dramatically shortens axons, but manipulation of LIMK1 activity did not alter dendrite growth in the same neurons, demonstrating compartment-specific LIMK1 regulation by BMPRII.","method":"In vivo Xenopus RGC experiments; wild-type and kinase-dead LIMK1 expression; BMPRII truncation mutant expression; axon and dendrite length quantification","journal":"Developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo genetic epistasis in Xenopus with multiple constructs, single lab","pmids":["19361494"],"is_preprint":false},{"year":2013,"finding":"Delta opioid receptor and ORL1 receptor agonists activate cofilin through a ROCK–LIMK–β-arrestin-1 pathway to regulate actin polymerization; this controls receptor function (inhibition of voltage-dependent Ca2+ channels in DRG neurons); behavioral effects of these agonists are enhanced in β-arrestin-1 knockout mice or prevented by ROCK inhibition.","method":"DRG neuron electrophysiology; β-arrestin-1 knockout mice; ROCK inhibitor (Y-27632); cofilin activation assay; behavioral assays","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic (KO mice) and pharmacological epistasis with functional electrophysiological and behavioral readouts, single lab","pmids":["24239352"],"is_preprint":false},{"year":2014,"finding":"LIMK-dependent actin polymerization in DRG primary sensory neurons promotes inflammatory heat hyperalgesia; inflammatory stimuli increase LIMK activity and cofilin phosphorylation in DRG; LIMK knockdown or prevention of cofilin phosphorylation attenuates hyperalgesia and blocks inflammatory enhancement of TRPV1 response and serine phosphorylation of TRPV1.","method":"In vivo rat CFA model; LIMK knockdown; cofilin phosphorylation assay; actin polymerization assay; TRPV1 electrophysiology; behavioral pain assays","journal":"Science signaling","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo model with LIMK knockdown, multiple orthogonal mechanistic readouts (kinase activity, actin polymerization, TRPV1 function, behavior), single lab with comprehensive mechanistic follow-up","pmids":["24962708"],"is_preprint":false},{"year":2018,"finding":"RhoA regulates the LIMK1/2-cofilin pathway during mouse oocyte meiosis: ROCK inhibition decreases p-LIMK1/2 and p-cofilin; LIMK1/2 disruption impairs spindle migration, polar body extrusion, and actin filament distribution; the pathway is ordered as RhoA→ROCK→LIMK1/2→cofilin.","method":"Mouse oocyte live-cell imaging; LIMK1/LIMK2 knockdown; ROCK inhibition; RhoA inhibition; cofilin phosphorylation immunoblotting; spindle morphology analysis","journal":"Journal of cellular physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic (KD) and pharmacological epistasis in a defined cellular system with multiple functional readouts, single lab","pmids":["29319181"],"is_preprint":false},{"year":2020,"finding":"LIMK1 mRNA stability is increased when the m6A reader YTHDC2 is downregulated, because YTHDC2 normally recognizes the GGACA m6A site on LIMK1 mRNA and promotes its degradation; elevated LIMK1 then facilitates eIF2α phosphorylation, ER stress, and stress granule formation, causing 5-FU chemoresistance.","method":"YTHDC2 siRNA knockdown; m6A site mutation; LIMK1 mRNA stability assay; eIF2α phosphorylation immunoblotting; stress granule immunofluorescence; 5-FU sensitivity assays","journal":"Cancer letters","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — m6A reader-mRNA mechanism with mutational validation and functional downstream readouts, single lab","pmids":["37778684"],"is_preprint":false},{"year":2021,"finding":"High NRG1 expression activates LIMK1 and increases cofilin phosphorylation in postsynaptic densities; inhibiting LIMK1 or blocking the NRG1-LIMK1 interaction rescues spine density reduction in ctoNrg1 mice overexpressing neuregulin-1.","method":"NRG1-overexpressing transgenic mice; LIMK1 inhibitor treatment; NRG1-LIMK1 interaction blocking; immunoblotting for p-cofilin; spine density quantification; mEPSC electrophysiology","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo transgenic model with pharmacological rescue and interaction blocking, multiple readouts, single lab","pmids":["33854034"],"is_preprint":false}],"current_model":"LIMK1 is a serine/threonine (and tyrosine) kinase whose principal substrate is cofilin, which it phosphorylates at Ser3 to inactivate this actin-depolymerizing factor and thereby stabilize F-actin; LIMK1 activity is controlled by upstream kinases (ROCK1/2, PAK1/2/4/6, PAK4 via MRCK-LRAP25, and PKA) that phosphorylate its activation loop, and is modulated by direct binding partners including BMPR-II (which inhibits then releases LIMK1 in response to BMP ligand), LATS1 (which inhibits LIMK1 during cytokinesis), TrkB (which activates LIMK1 via dimerization/transphosphorylation), DAPK (which scaffolds the LIMK/cofilin complex during TNF-induced apoptosis), and fascin-1; LIMK1 localizes to the Golgi (via its LIM domain), growth cones (via its PDZ domain), and spindle poles/cleavage furrow during mitosis; beyond cofilin, LIMK1 also phosphorylates tyrosine Y573 of MT1-MMP to regulate invadopodia and matrix degradation, and interacts with the transcription factor CREB to support long-term memory; in vivo, LIMK1 is essential for dendritic spine morphogenesis, hippocampal LTP, long-term memory formation, cortical neuronal progenitor proliferation and migration, and inflammatory pain sensitization via TRPV1 regulation."},"narrative":{"mechanistic_narrative":"LIMK1 is a serine/threonine protein kinase that links upstream Rho-family signaling to actin cytoskeletal remodeling by phosphorylating the actin-depolymerizing factor cofilin at Ser3, thereby stabilizing F-actin [PMID:12123613, PMID:12775580]. Its catalytic activity depends on the conserved IHRDL active-site residue D460, and the enzyme autophosphorylates on serine, threonine, and tyrosine [PMID:7478547]; crystal structures of the kinase domain define its 'rock-and-poke' catalytic mechanism, substrate specificity, and dependence on activation-loop phosphorylation [PMID:31652302]. LIMK1 is engaged downstream of ROCK in mechanosensing and stress-fiber maintenance [PMID:12775580, PMID:15199148], and is activated by multiple upstream kinases through phosphorylation of its activation loop (Thr508), including PAK2, PAK4, PAK6, and PKA [PMID:15908432, PMID:18424072, PMID:19424295, PMID:25714010]. Its output is locally controlled by direct binding partners: BMPR-II binds and inhibits LIMK1 until BMP ligand relieves the block and Cdc42 synergizes to activate it during dendritogenesis and axon extension [PMID:12963706, PMID:15538389, PMID:19361494]; LATS1 inhibits LIMK1 at the contractile ring during cytokinesis [PMID:15220930]; TrkB drives BDNF-dependent LIMK1 dimerization and transphosphorylation [PMID:23086941]; and adaptors such as LRAP25-MRCK confine LIMK1 activation to the lamellipodium [PMID:25107909]. LIMK1 localizes to the Golgi via its LIM domain and to growth cones via its PDZ domain, where it regulates vesicle traffic and axon formation [PMID:15090620], and it shows cell-cycle-dependent redistribution to spindle poles and the cleavage furrow [PMID:16455074]. Beyond cofilin, LIMK1 phosphorylates Tyr573 of MT1-MMP to regulate invadopodia and matrix degradation [PMID:27116935]. In vivo, LIMK1 controls dendritic spine morphology, hippocampal LTP, and—via interaction with CREB—late-phase LTP and long-term memory [PMID:12123613, PMID:25645926], and LIMK-dependent actin remodeling in sensory neurons drives inflammatory heat hyperalgesia through TRPV1 [PMID:24962708]. ROCK2-LIMK1 signaling mediates Aβ42-induced dendritic spine degeneration, and LIMK1 inhibition rescues spine loss in an Alzheimer's disease mouse model [PMID:31239325].","teleology":[{"year":1995,"claim":"Established that LIMK1 is a catalytically active protein kinase and identified the active-site residue required for activity, defining its enzymatic identity.","evidence":"In vitro kinase/autophosphorylation assays with GST-Limk1 and D460A active-site mutagenesis; MBP substrate phosphorylation","pmids":["7478547","7651734"],"confidence":"High","gaps":["Physiological substrate not yet identified","No structural basis for catalysis","Upstream activators unknown"]},{"year":2002,"claim":"Defined cofilin as the in vivo LIMK1 substrate and connected the kinase to spine morphogenesis and synaptic plasticity, moving LIMK1 from a biochemical activity to a physiological regulator of the actin cytoskeleton.","evidence":"LIMK1 knockout mice with p-cofilin immunoblotting, LTP electrophysiology, and learning/memory behavioral tests","pmids":["12123613"],"confidence":"High","gaps":["Upstream activating signals in neurons not resolved","Direct CREB/transcriptional link not yet established","Mechanism of spine actin regulation not fully defined"]},{"year":2003,"claim":"Identified BMPR-II as a direct binding partner that inhibits LIMK1 until BMP ligand relieves the block, establishing a ligand-gated mode of LIMK1 regulation and a Smad-independent BMP pathway.","evidence":"Yeast two-hybrid, Co-IP, in vitro cofilin phosphorylation, and PPH-associated truncation mutant analysis","pmids":["12963706"],"confidence":"High","gaps":["Structural basis of inhibition not defined","How ligand binding relieves inhibition mechanistically unclear"]},{"year":2003,"claim":"Placed LIMK1 within the Rho-ROCK-cofilin mechanosensing cascade, ordering it downstream of ROCK and upstream of cofilin.","evidence":"Dominant-negative epistasis (RhoA, ROCK, LIMK, cofilin) with SREBP reporter assays in endothelial cells","pmids":["12775580"],"confidence":"Medium","gaps":["Direct ROCK phosphorylation of LIMK1 not shown here","Restricted to a single signaling output (SREBP)"]},{"year":2004,"claim":"Resolved LIMK1 subcellular targeting and demonstrated domain-specific localization with functional consequences for Golgi traffic and axon formation.","evidence":"Confocal microscopy, fractionation, wild-type vs kinase-dead constructs, and constitutively active cofilin rescue","pmids":["15090620","16455074"],"confidence":"High","gaps":["LIM-domain Golgi anchor partner not identified","Functional role of spindle-pole/cleavage-furrow localization not tested"]},{"year":2004,"claim":"Identified LATS1 and BMPR-II/Cdc42 as context-specific regulators, showing LIMK1 is negatively controlled during cytokinesis and positively activated during dendritogenesis.","evidence":"GST pull-down, Co-IP, immunofluorescence, antibody microinjection, siRNA, and KO mice (LATS1); reciprocal Co-IP and dendrite assays (BMPR-II/Cdc42)","pmids":["15220930","15538389"],"confidence":"High","gaps":["Mechanism by which LATS1 inhibits the kinase unresolved","How Cdc42 synergizes with BMPR-II binding not structurally defined"]},{"year":2005,"claim":"Mapped multiple PAK-family kinases as direct upstream activators that phosphorylate LIMK1's activation loop, establishing PAK→LIMK1→cofilin as a recurring motility axis.","evidence":"siRNA epistasis, Co-IP, FRET-FLIM, in vitro phosphorylation (including Thr508 mapping), and migration/invasion assays across PAK2, PAK4, PAK6","pmids":["15908432","18424072","25714010"],"confidence":"High","gaps":["Selectivity among PAK isoforms in different tissues not resolved","Quantitative contribution of each PAK to activation-loop phosphorylation unclear"]},{"year":2009,"claim":"Demonstrated a Rho-independent route to LIMK1 activation via direct PKA phosphorylation, broadening the upstream input map beyond Rho-GTPase signaling.","evidence":"Prkar1a-/- MEFs, pharmacological PKA activation, in vitro phosphorylation of Limk1 by PKA, and Rho/Rac inhibitor epistasis","pmids":["19424295"],"confidence":"High","gaps":["PKA target residue on LIMK1 not defined","Crosstalk with Rho-driven activation not characterized"]},{"year":2012,"claim":"Expanded LIMK1 regulation to receptor- and scaffold-driven mechanisms—TrkB-induced dimerization/transphosphorylation, fascin-1 complex formation, and LRAP25-MRCK localized activation.","evidence":"Reciprocal Co-IP, FRET-FLIM, dominant-negative constructs, and functional actin/migration readouts","pmids":["23086941","22883572","25107909"],"confidence":"Medium","gaps":["Stoichiometry of LIMK1 dimers not defined","Direct vs indirect nature of some interactions not fully validated"]},{"year":2013,"claim":"Identified DAPK as a scaffold for the LIMK/cofilin complex in TNF-induced apoptosis, linking LIMK1 to programmed cell death signaling.","evidence":"Peptide array, siRNA, DAPK inhibitor and overexpression, phospho-immunoblotting (LIMK Thr508, cofilin Ser3), and immunofluorescence","pmids":["23702034"],"confidence":"Medium","gaps":["Whether DAPK directly phosphorylates LIMK1 not established","Structural model is computational"]},{"year":2015,"claim":"Established a LIMK1→CREB axis required selectively for late-phase LTP and long-term memory, revealing a transcriptional output distinct from acute actin regulation.","evidence":"LIMK1 KO mice, Co-IP for LIMK1-CREB interaction, L-LTP electrophysiology, memory testing, and CREB-activator rescue","pmids":["25645926"],"confidence":"High","gaps":["Mechanism by which LIMK1 regulates CREB activity unresolved","Whether kinase activity is required for the CREB effect not defined"]},{"year":2016,"claim":"Identified MT1-MMP Tyr573 as a non-cofilin LIMK1 substrate, demonstrating that LIMK1 directly regulates invadopodia and matrix degradation beyond actin filament dynamics.","evidence":"Co-IP, in vitro kinase assay mapping Y573, Y573 mutagenesis, cortactin association, and invadopodia/matrix degradation assays","pmids":["27116935"],"confidence":"High","gaps":["Full repertoire of non-cofilin substrates unknown","Tyrosine kinase activity scope not broadly characterized"]},{"year":2019,"claim":"Demonstrated disease-relevant LIMK1 functions—ROCK2-LIMK1 mediating Aβ42-induced spine degeneration with inhibitor rescue—while delineating where LIMK1 is dispensable (apoptotic blebbing) and solving the kinase-domain structure.","evidence":"Hippocampal cultures, ROCK1/2 dissection, LIMK1 inhibitor in hAPP mice (spine loss); CRISPR LIMK1 KO negative result for blebbing; X-ray crystallography with inhibitors","pmids":["31239325","31043701","31652302"],"confidence":"High","gaps":["In vivo selectivity of LIMK1 inhibitors not fully addressed","Structural basis for partner-mediated regulation not captured in isolated kinase-domain structures"]},{"year":2014,"claim":"Established LIMK1-dependent actin remodeling as a driver of inflammatory pain via TRPV1 regulation, linking the kinase to nociceptor sensitization.","evidence":"In vivo CFA rat model, LIMK knockdown, cofilin phosphorylation and actin polymerization assays, and TRPV1 electrophysiology/behavior","pmids":["24962708"],"confidence":"High","gaps":["Mechanism connecting actin polymerization to TRPV1 phosphorylation not fully defined","Whether LIMK1 acts on TRPV1 directly not established"]},{"year":2020,"claim":"Identified post-transcriptional control of LIMK1 by m6A reader YTHDC2, linking LIMK1 abundance to ER stress and chemoresistance.","evidence":"YTHDC2 siRNA, m6A site mutation, mRNA stability assay, eIF2α phospho-immunoblotting, and 5-FU sensitivity assays","pmids":["37778684"],"confidence":"Medium","gaps":["Generality of LIMK1 m6A regulation across tissues unknown","Mechanism by which LIMK1 promotes eIF2α phosphorylation unclear"]},{"year":null,"claim":"How LIMK1's diverse upstream inputs (Rho-ROCK, PAK isoforms, PKA, receptor-driven dimerization) and binding-partner-imposed inhibition are integrated to produce substrate- and compartment-specific outputs remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified structural model of partner-regulated activation","Full substrate repertoire beyond cofilin and MT1-MMP undefined","Quantitative logic of input integration not established"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,2,3,20,25]},{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[0,1,20]},{"term_id":"GO:0008092","term_label":"cytoskeletal protein binding","supporting_discovery_ids":[2,14]}],"localization":[{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[5]},{"term_id":"GO:0005856","term_label":"cytoskeleton","supporting_discovery_ids":[5,8,17]},{"term_id":"GO:0005815","term_label":"microtubule organizing center","supporting_discovery_ids":[10]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[19]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[3,4,7,12,13]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[2,18,21,22,28]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[6,10,29]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[7,15,26]}],"complexes":[],"partners":["CFL1","BMPR2","LATS1","PAK4","PAK6","NTRK2","MMP14","FSCN1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P53667","full_name":"LIM domain kinase 1","aliases":[],"length_aa":647,"mass_kda":72.6,"function":"Serine/threonine-protein kinase that plays an essential role in the regulation of actin filament dynamics. Acts downstream of several Rho family GTPase signal transduction pathways (PubMed:10436159, PubMed:11832213, PubMed:12807904, PubMed:15660133, PubMed:16230460, PubMed:18028908, PubMed:22328514, PubMed:23633677). Activated by upstream kinases including ROCK1, PAK1 and PAK4, which phosphorylate LIMK1 on a threonine residue located in its activation loop (PubMed:10436159). LIMK1 subsequently phosphorylates and inactivates the actin binding/depolymerizing factors cofilin-1/CFL1, cofilin-2/CFL2 and destrin/DSTN, thereby preventing the cleavage of filamentous actin (F-actin), and stabilizing the actin cytoskeleton (PubMed:11832213, PubMed:15660133, PubMed:16230460, PubMed:23633677). In this way LIMK1 regulates several actin-dependent biological processes including cell motility, cell cycle progression, and differentiation (PubMed:11832213, PubMed:15660133, PubMed:16230460, PubMed:23633677). Phosphorylates TPPP on serine residues, thereby promoting microtubule disassembly (PubMed:18028908). Stimulates axonal outgrowth and may be involved in brain development (PubMed:18028908) Has a dominant negative effect on actin cytoskeletal changes. Required for atypical chemokine receptor ACKR2-induced phosphorylation of cofilin (CFL1)","subcellular_location":"Cytoplasm; Nucleus; Cytoplasm, cytoskeleton; Cell projection, lamellipodium","url":"https://www.uniprot.org/uniprotkb/P53667/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/LIMK1","classification":"Not Classified","n_dependent_lines":5,"n_total_lines":1208,"dependency_fraction":0.0041390728476821195},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/LIMK1","total_profiled":1310},"omim":[{"mim_id":"616130","title":"LEUCINE-RICH ADAPTOR PROTEIN 1-LIKE; LURAP1L","url":"https://www.omim.org/entry/616130"},{"mim_id":"616128","title":"FAMILY WITH SEQUENCE SIMILARITY 89, MEMBER B; FAM89B","url":"https://www.omim.org/entry/616128"},{"mim_id":"615507","title":"NISCHARIN; NISCH","url":"https://www.omim.org/entry/615507"},{"mim_id":"610164","title":"MICRO RNA 134; MIRN134","url":"https://www.omim.org/entry/610164"},{"mim_id":"608764","title":"NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; NAMPT","url":"https://www.omim.org/entry/608764"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nuclear speckles","reliability":"Supported"},{"location":"Cytosol","reliability":"Supported"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"brain","ntpm":87.1}],"url":"https://www.proteinatlas.org/search/LIMK1"},"hgnc":{"alias_symbol":["LIMK"],"prev_symbol":[]},"alphafold":{"accession":"P53667","domains":[{"cath_id":"2.10.110.10","chopping":"5-14_22-79","consensus_level":"high","plddt":76.3579,"start":5,"end":79},{"cath_id":"2.30.42.10","chopping":"97-185_197-255","consensus_level":"high","plddt":80.6868,"start":97,"end":255},{"cath_id":"3.30.200.20","chopping":"331-413","consensus_level":"high","plddt":84.4937,"start":331,"end":413},{"cath_id":"1.10.510.10","chopping":"421-633","consensus_level":"high","plddt":88.1136,"start":421,"end":633}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P53667","model_url":"https://alphafold.ebi.ac.uk/files/AF-P53667-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P53667-F1-predicted_aligned_error_v6.png","plddt_mean":75.19},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=LIMK1","jax_strain_url":"https://www.jax.org/strain/search?query=LIMK1"},"sequence":{"accession":"P53667","fasta_url":"https://rest.uniprot.org/uniprotkb/P53667.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P53667/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P53667"}},"corpus_meta":[{"pmid":"12123613","id":"PMC_12123613","title":"Abnormal spine morphology and enhanced LTP in LIMK-1 knockout mice.","date":"2002","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/12123613","citation_count":551,"is_preprint":false},{"pmid":"12963706","id":"PMC_12963706","title":"Direct signaling by the BMP type II receptor via the cytoskeletal regulator LIMK1.","date":"2003","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/12963706","citation_count":268,"is_preprint":false},{"pmid":"15538389","id":"PMC_15538389","title":"Activation of LIMK1 by binding to the BMP receptor, BMPRII, regulates BMP-dependent dendritogenesis.","date":"2004","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/15538389","citation_count":180,"is_preprint":false},{"pmid":"15220930","id":"PMC_15220930","title":"LATS1 tumour suppressor affects cytokinesis by inhibiting LIMK1.","date":"2004","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/15220930","citation_count":154,"is_preprint":false},{"pmid":"15908432","id":"PMC_15908432","title":"Binding of activated alpha2-macroglobulin to its cell surface receptor GRP78 in 1-LN prostate cancer cells regulates PAK-2-dependent activation of LIMK.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15908432","citation_count":152,"is_preprint":false},{"pmid":"18424072","id":"PMC_18424072","title":"A PAK4-LIMK1 pathway drives prostate cancer cell migration downstream of HGF.","date":"2008","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/18424072","citation_count":123,"is_preprint":false},{"pmid":"15090620","id":"PMC_15090620","title":"LIMK1 regulates Golgi dynamics, traffic of Golgi-derived vesicles, and process extension in primary cultured neurons.","date":"2004","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/15090620","citation_count":111,"is_preprint":false},{"pmid":"12775580","id":"PMC_12775580","title":"Rho-ROCK-LIMK-cofilin pathway regulates shear stress activation of sterol regulatory element binding proteins.","date":"2003","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/12775580","citation_count":105,"is_preprint":false},{"pmid":"7478547","id":"PMC_7478547","title":"Limk1 is predominantly expressed in neural tissues and phosphorylates serine, threonine and tyrosine residues in vitro.","date":"1995","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/7478547","citation_count":102,"is_preprint":false},{"pmid":"31030376","id":"PMC_31030376","title":"Targeting ROCK/LIMK/cofilin signaling pathway in cancer.","date":"2019","source":"Archives of pharmacal research","url":"https://pubmed.ncbi.nlm.nih.gov/31030376","citation_count":87,"is_preprint":false},{"pmid":"15199148","id":"PMC_15199148","title":"B-Raf acts via the ROCKII/LIMK/cofilin pathway to maintain actin stress fibers in fibroblasts.","date":"2004","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15199148","citation_count":87,"is_preprint":false},{"pmid":"7651734","id":"PMC_7651734","title":"LIMK-1 and LIMK-2, two members of a LIM motif-containing protein kinase family.","date":"1995","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/7651734","citation_count":86,"is_preprint":false},{"pmid":"12606349","id":"PMC_12606349","title":"Sertoli-germ cell adherens junction dynamics in the testis are regulated by RhoB GTPase via the ROCK/LIMK signaling pathway.","date":"2003","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/12606349","citation_count":85,"is_preprint":false},{"pmid":"20047470","id":"PMC_20047470","title":"LIMK1 and LIMK2 are important for metastatic behavior and tumor cell-induced angiogenesis of pancreatic cancer cells.","date":"2009","source":"Zebrafish","url":"https://pubmed.ncbi.nlm.nih.gov/20047470","citation_count":82,"is_preprint":false},{"pmid":"14513866","id":"PMC_14513866","title":"Regulation of spine morphology and synaptic function by LIMK and the actin cytoskeleton.","date":"2003","source":"Reviews in the neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/14513866","citation_count":81,"is_preprint":false},{"pmid":"26880202","id":"PMC_26880202","title":"Neuroligin 1 regulates spines and synaptic plasticity via LIMK1/cofilin-mediated actin reorganization.","date":"2016","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/26880202","citation_count":81,"is_preprint":false},{"pmid":"31038266","id":"PMC_31038266","title":"DANCR promotes HCC progression and regulates EMT by sponging miR-27a-3p via ROCK1/LIMK1/COFILIN1 pathway.","date":"2019","source":"Cell proliferation","url":"https://pubmed.ncbi.nlm.nih.gov/31038266","citation_count":76,"is_preprint":false},{"pmid":"31239325","id":"PMC_31239325","title":"Pharmacologic inhibition of LIMK1 provides dendritic spine resilience against β-amyloid.","date":"2019","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/31239325","citation_count":75,"is_preprint":false},{"pmid":"24390089","id":"PMC_24390089","title":"MiR-27b targets LIMK1 to inhibit growth and invasion of NSCLC cells.","date":"2014","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24390089","citation_count":69,"is_preprint":false},{"pmid":"14745832","id":"PMC_14745832","title":"LIMK1 and CLIP-115: linking cytoskeletal defects to Williams syndrome.","date":"2004","source":"BioEssays : news and reviews in molecular, cellular and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/14745832","citation_count":67,"is_preprint":false},{"pmid":"25714010","id":"PMC_25714010","title":"Downregulation of microRNA-23a suppresses prostate cancer metastasis by targeting the PAK6-LIMK1 signaling pathway.","date":"2015","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/25714010","citation_count":67,"is_preprint":false},{"pmid":"27116935","id":"PMC_27116935","title":"LIMK Regulates Tumor-Cell Invasion and Matrix Degradation Through Tyrosine Phosphorylation of MT1-MMP.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27116935","citation_count":63,"is_preprint":false},{"pmid":"19424295","id":"PMC_19424295","title":"Regulation of actin function by protein kinase A-mediated phosphorylation of Limk1.","date":"2009","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/19424295","citation_count":63,"is_preprint":false},{"pmid":"31043701","id":"PMC_31043701","title":"ROCK1 but not LIMK1 or PAK2 is a key regulator of apoptotic membrane blebbing and cell disassembly.","date":"2019","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/31043701","citation_count":61,"is_preprint":false},{"pmid":"25645926","id":"PMC_25645926","title":"LIMK1 regulates long-term memory and synaptic plasticity via the transcriptional factor CREB.","date":"2015","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/25645926","citation_count":59,"is_preprint":false},{"pmid":"19778628","id":"PMC_19778628","title":"DGCR6L, a novel PAK4 interaction protein, regulates PAK4-mediated migration of human gastric cancer cell via LIMK1.","date":"2009","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/19778628","citation_count":59,"is_preprint":false},{"pmid":"32767662","id":"PMC_32767662","title":"Exosomal lncRNA H19 promotes the progression of hepatocellular carcinoma treated with Propofol via miR-520a-3p/LIMK1 axis.","date":"2020","source":"Cancer medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32767662","citation_count":58,"is_preprint":false},{"pmid":"21682918","id":"PMC_21682918","title":"Nuclear and cytoplasmic LIMK1 enhances human breast cancer progression.","date":"2011","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/21682918","citation_count":56,"is_preprint":false},{"pmid":"28116173","id":"PMC_28116173","title":"Electroacupuncture Regulates Hippocampal Synaptic Plasticity via miR-134-Mediated LIMK1 Function in Rats with Ischemic Stroke.","date":"2017","source":"Neural plasticity","url":"https://pubmed.ncbi.nlm.nih.gov/28116173","citation_count":56,"is_preprint":false},{"pmid":"26871290","id":"PMC_26871290","title":"Diallyl disulfide suppresses epithelial-mesenchymal transition, invasion and proliferation by downregulation of LIMK1 in gastric cancer.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/26871290","citation_count":55,"is_preprint":false},{"pmid":"33982869","id":"PMC_33982869","title":"Targeting LIMK1 with luteolin inhibits the growth of lung cancer in vitro and in vivo.","date":"2021","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33982869","citation_count":54,"is_preprint":false},{"pmid":"31078043","id":"PMC_31078043","title":"MiR-128-3p suppresses breast cancer cellular progression via targeting LIMK1.","date":"2019","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/31078043","citation_count":54,"is_preprint":false},{"pmid":"23233092","id":"PMC_23233092","title":"DADS downregulates the Rac1-ROCK1/PAK1-LIMK1-ADF/cofilin signaling pathway, inhibiting cell migration and invasion.","date":"2012","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/23233092","citation_count":53,"is_preprint":false},{"pmid":"33414429","id":"PMC_33414429","title":"Long noncoding RNA LINC00941 promotes pancreatic cancer progression by competitively binding miR-335-5p to regulate ROCK1-mediated LIMK1/Cofilin-1 signaling.","date":"2021","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/33414429","citation_count":52,"is_preprint":false},{"pmid":"9149099","id":"PMC_9149099","title":"Comparison of tissue distribution of two novel serine/threonine kinase genes containing the LIM motif (LIMK-1 and LIMK-2) in the developing rat.","date":"1997","source":"Brain research. Molecular brain research","url":"https://pubmed.ncbi.nlm.nih.gov/9149099","citation_count":49,"is_preprint":false},{"pmid":"16611674","id":"PMC_16611674","title":"A haplotype spanning two genes, ELN and LIMK1, decreases their transcripts and confers susceptibility to intracranial aneurysms.","date":"2006","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16611674","citation_count":48,"is_preprint":false},{"pmid":"8541208","id":"PMC_8541208","title":"The murine LIM-kinase gene (limk) encodes a novel serine threonine kinase expressed predominantly in trophoblast giant cells and the developing nervous system.","date":"1995","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/8541208","citation_count":48,"is_preprint":false},{"pmid":"31176122","id":"PMC_31176122","title":"Baicalin regulates depression behavior in mice exposed to chronic mild stress via the Rac/LIMK/cofilin pathway.","date":"2019","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/31176122","citation_count":47,"is_preprint":false},{"pmid":"36899941","id":"PMC_36899941","title":"LIM Kinases, LIMK1 and LIMK2, Are Crucial Node Actors of the Cell Fate: Molecular to Pathological Features.","date":"2023","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/36899941","citation_count":46,"is_preprint":false},{"pmid":"28358024","id":"PMC_28358024","title":"Downregulation of LIMK1-ADF/cofilin by DADS inhibits the migration and invasion of colon cancer.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28358024","citation_count":46,"is_preprint":false},{"pmid":"25003638","id":"PMC_25003638","title":"miR-143 inhibits NSCLC cell growth and metastasis by targeting Limk1.","date":"2014","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/25003638","citation_count":45,"is_preprint":false},{"pmid":"24239352","id":"PMC_24239352","title":"Select G-protein-coupled receptors modulate agonist-induced signaling via a ROCK, LIMK, and β-arrestin 1 pathway.","date":"2013","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/24239352","citation_count":44,"is_preprint":false},{"pmid":"22883572","id":"PMC_22883572","title":"A novel Rho-dependent pathway that drives interaction of fascin-1 with p-Lin-11/Isl-1/Mec-3 kinase (LIMK) 1/2 to promote fascin-1/actin binding and filopodia stability.","date":"2012","source":"BMC biology","url":"https://pubmed.ncbi.nlm.nih.gov/22883572","citation_count":43,"is_preprint":false},{"pmid":"25621531","id":"PMC_25621531","title":"Bis-aryl urea derivatives as potent and selective LIM kinase (Limk) inhibitors.","date":"2015","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25621531","citation_count":42,"is_preprint":false},{"pmid":"29352327","id":"PMC_29352327","title":"LIMK/cofilin pathway and Slingshot are implicated in human colorectal cancer progression and chemoresistance.","date":"2018","source":"Virchows Archiv : an international journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/29352327","citation_count":40,"is_preprint":false},{"pmid":"33883692","id":"PMC_33883692","title":"LIMK1 promotes peritoneal metastasis of gastric cancer and is a therapeutic target.","date":"2021","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/33883692","citation_count":39,"is_preprint":false},{"pmid":"30484785","id":"PMC_30484785","title":"Recombinant human BMP-2 accelerates the migration of bone marrow mesenchymal stem cells via the CDC42/PAK1/LIMK1 pathway in vitro and in vivo.","date":"2018","source":"Biomaterials science","url":"https://pubmed.ncbi.nlm.nih.gov/30484785","citation_count":39,"is_preprint":false},{"pmid":"37778684","id":"PMC_37778684","title":"LIMK1 m6A-RNA methylation recognized by YTHDC2 induces 5-FU chemoresistance in colorectal cancer via endoplasmic reticulum stress and stress granule formation.","date":"2023","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/37778684","citation_count":38,"is_preprint":false},{"pmid":"10512679","id":"PMC_10512679","title":"Identification and characterization of TESK2, a novel member of the LIMK/TESK family of protein kinases, predominantly expressed in testis.","date":"1999","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/10512679","citation_count":38,"is_preprint":false},{"pmid":"25019203","id":"PMC_25019203","title":"MiR-20a inhibits cutaneous squamous cell carcinoma metastasis and proliferation by directly targeting LIMK1.","date":"2014","source":"Cancer biology & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/25019203","citation_count":37,"is_preprint":false},{"pmid":"16455074","id":"PMC_16455074","title":"Different activity regulation and subcellular localization of LIMK1 and LIMK2 during cell cycle transition.","date":"2006","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/16455074","citation_count":37,"is_preprint":false},{"pmid":"31277940","id":"PMC_31277940","title":"GPER stabilizes F-actin cytoskeleton and activates TAZ via PLCβ-PKC and Rho/ROCK-LIMK-Cofilin pathway.","date":"2019","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/31277940","citation_count":34,"is_preprint":false},{"pmid":"29970879","id":"PMC_29970879","title":"Imbalanced LIMK1 and LIMK2 expression leads to human colorectal cancer progression and metastasis via promoting β-catenin nuclear translocation.","date":"2018","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/29970879","citation_count":34,"is_preprint":false},{"pmid":"33968977","id":"PMC_33968977","title":"SphK2/S1P Promotes Metastasis of Triple-Negative Breast Cancer Through the PAK1/LIMK1/Cofilin1 Signaling Pathway.","date":"2021","source":"Frontiers in molecular biosciences","url":"https://pubmed.ncbi.nlm.nih.gov/33968977","citation_count":34,"is_preprint":false},{"pmid":"32594801","id":"PMC_32594801","title":"LIMK (LIM Kinase) Inhibition Prevents Vasoconstriction- and Hypertension-Induced Arterial Stiffening and Remodeling.","date":"2020","source":"Hypertension (Dallas, Tex. : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/32594801","citation_count":33,"is_preprint":false},{"pmid":"33344441","id":"PMC_33344441","title":"Dasatinib Inhibits Lung Cancer Cell Growth and Patient Derived Tumor Growth in Mice by Targeting LIMK1.","date":"2020","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/33344441","citation_count":33,"is_preprint":false},{"pmid":"25661344","id":"PMC_25661344","title":"Overexpression of LIMK1 promotes tumor growth and metastasis in gastric cancer.","date":"2014","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/25661344","citation_count":33,"is_preprint":false},{"pmid":"21074289","id":"PMC_21074289","title":"Differing contributions of LIMK and ROCK to TGFβ-induced transcription, motility and invasion.","date":"2010","source":"European journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/21074289","citation_count":31,"is_preprint":false},{"pmid":"23086941","id":"PMC_23086941","title":"LIM kinase 1 (LIMK1) interacts with tropomyosin-related kinase B (TrkB) and Mediates brain-derived neurotrophic factor (BDNF)-induced axonal elongation.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23086941","citation_count":30,"is_preprint":false},{"pmid":"22802696","id":"PMC_22802696","title":"Pak1/LIMK1/Cofilin Pathway Contributes to Tumor Migration and Invasion in Human Non-Small Cell Lung Carcinomas and Cell Lines.","date":"2012","source":"The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/22802696","citation_count":30,"is_preprint":false},{"pmid":"25119502","id":"PMC_25119502","title":"EBP50 inhibits the migration and invasion of human breast cancer cells via LIMK/cofilin and the PI3K/Akt/mTOR/MMP signaling pathway.","date":"2014","source":"Medical oncology (Northwood, London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/25119502","citation_count":30,"is_preprint":false},{"pmid":"24063279","id":"PMC_24063279","title":"Downregulation of LIMK1 level inhibits migration of lung cancer cells and enhances sensitivity to chemotherapy drugs.","date":"2013","source":"Oncology research","url":"https://pubmed.ncbi.nlm.nih.gov/24063279","citation_count":30,"is_preprint":false},{"pmid":"34079084","id":"PMC_34079084","title":"Long non-coding RNA Lnc-408 promotes invasion and metastasis of breast cancer cell by regulating LIMK1.","date":"2021","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/34079084","citation_count":29,"is_preprint":false},{"pmid":"31112612","id":"PMC_31112612","title":"Actin Dynamics, Regulated by RhoA-LIMK-Cofilin Signaling, Mediates Rod Photoreceptor Axonal Retraction After Retinal Injury.","date":"2019","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/31112612","citation_count":29,"is_preprint":false},{"pmid":"28806779","id":"PMC_28806779","title":"A mutation in Nischarin causes otitis media via LIMK1 and NF-κB pathways.","date":"2017","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/28806779","citation_count":29,"is_preprint":false},{"pmid":"32110046","id":"PMC_32110046","title":"DEP Domain-Containing Protein 1B (DEPDC1B) Promotes Migration and Invasion in Pancreatic Cancer Through the Rac1/PAK1-LIMK1-Cofilin1 Signaling Pathway.","date":"2020","source":"OncoTargets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/32110046","citation_count":29,"is_preprint":false},{"pmid":"20347121","id":"PMC_20347121","title":"Coagulation Factor Xa inhibits cancer cell migration via LIMK1-mediated cofilin inactivation.","date":"2010","source":"Thrombosis research","url":"https://pubmed.ncbi.nlm.nih.gov/20347121","citation_count":28,"is_preprint":false},{"pmid":"22537493","id":"PMC_22537493","title":"Cadherin-6B stimulates an epithelial mesenchymal transition and the delamination of cells from the neural ectoderm via LIMK/cofilin mediated non-canonical BMP receptor signaling.","date":"2012","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/22537493","citation_count":28,"is_preprint":false},{"pmid":"23437279","id":"PMC_23437279","title":"ECM-dependent HIF induction directs trophoblast stem cell fate via LIMK1-mediated cytoskeletal rearrangement.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23437279","citation_count":27,"is_preprint":false},{"pmid":"34447368","id":"PMC_34447368","title":"IP-10 Promotes Latent HIV Infection in Resting Memory CD4+ T Cells via LIMK-Cofilin Pathway.","date":"2021","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/34447368","citation_count":27,"is_preprint":false},{"pmid":"35011704","id":"PMC_35011704","title":"Structural Aspects of LIMK Regulation and Pharmacology.","date":"2022","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/35011704","citation_count":26,"is_preprint":false},{"pmid":"31389670","id":"PMC_31389670","title":"Nonconserved miR-608 suppresses prostate cancer progression through RAC2/PAK4/LIMK1 and BCL2L1/caspase-3 pathways by targeting the 3'-UTRs of RAC2/BCL2L1 and the coding region of PAK4.","date":"2019","source":"Cancer medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31389670","citation_count":26,"is_preprint":false},{"pmid":"27216618","id":"PMC_27216618","title":"Simvastatin Attenuates Neuropathic Pain by Inhibiting the RhoA/LIMK/Cofilin Pathway.","date":"2016","source":"Neurochemical research","url":"https://pubmed.ncbi.nlm.nih.gov/27216618","citation_count":26,"is_preprint":false},{"pmid":"33854034","id":"PMC_33854034","title":"Spine impairment in mice high-expressing neuregulin 1 due to LIMK1 activation.","date":"2021","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/33854034","citation_count":25,"is_preprint":false},{"pmid":"31026254","id":"PMC_31026254","title":"Rho-Associated Protein Kinase (ROCK) Promotes Proliferation and Migration of PC-3 and DU145 Prostate Cancer Cells by Targeting LIM Kinase 1 (LIMK1) and Matrix Metalloproteinase-2 (MMP-2).","date":"2019","source":"Medical science monitor : international medical journal of experimental and clinical research","url":"https://pubmed.ncbi.nlm.nih.gov/31026254","citation_count":25,"is_preprint":false},{"pmid":"26233434","id":"PMC_26233434","title":"Design, synthesis and biological characterization of selective LIMK inhibitors.","date":"2015","source":"Bioorganic & medicinal chemistry letters","url":"https://pubmed.ncbi.nlm.nih.gov/26233434","citation_count":25,"is_preprint":false},{"pmid":"11003705","id":"PMC_11003705","title":"Comparative genomic sequence analysis of the Williams syndrome region (LIMK1-RFC2) of human chromosome 7q11.23.","date":"2000","source":"Mammalian genome : official journal of the International Mammalian Genome Society","url":"https://pubmed.ncbi.nlm.nih.gov/11003705","citation_count":25,"is_preprint":false},{"pmid":"31652302","id":"PMC_31652302","title":"Lessons from LIMK1 enzymology and their impact on inhibitor design.","date":"2019","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/31652302","citation_count":24,"is_preprint":false},{"pmid":"32697981","id":"PMC_32697981","title":"Cofilin Inhibition by Limk1 Reduces Rod Formation and Cell Apoptosis after Ischemic Stroke.","date":"2020","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/32697981","citation_count":24,"is_preprint":false},{"pmid":"24962708","id":"PMC_24962708","title":"LIMK-dependent actin polymerization in primary sensory neurons promotes the development of inflammatory heat hyperalgesia in rats.","date":"2014","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/24962708","citation_count":24,"is_preprint":false},{"pmid":"15066125","id":"PMC_15066125","title":"CD29 integrin- and LIMK1/cofilin-mediated actin reorganization regulates the migration of haematopoietic progenitor cells underneath bone marrow stromal cells.","date":"2004","source":"Genes to cells : devoted to molecular & cellular mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/15066125","citation_count":24,"is_preprint":false},{"pmid":"32463132","id":"PMC_32463132","title":"Effects of PAK4/LIMK1/Cofilin-1 signaling pathway on proliferation, invasion, and migration of human osteosarcoma cells.","date":"2020","source":"Journal of clinical laboratory analysis","url":"https://pubmed.ncbi.nlm.nih.gov/32463132","citation_count":23,"is_preprint":false},{"pmid":"32860848","id":"PMC_32860848","title":"Knockdown of RhoGDI2 represses human gastric cancer cell proliferation, invasion and drug resistance via the Rac1/Pak1/LIMK1 pathway.","date":"2020","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/32860848","citation_count":23,"is_preprint":false},{"pmid":"27973945","id":"PMC_27973945","title":"Sevoflurane induces cognitive impairments via the MiR-27b/LIMK1-signaling pathway in developing rats.","date":"2016","source":"Inhalation toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/27973945","citation_count":23,"is_preprint":false},{"pmid":"31319858","id":"PMC_31319858","title":"LIMK1 and LIMK2 regulate cortical development through affecting neural progenitor cell proliferation and migration.","date":"2019","source":"Molecular brain","url":"https://pubmed.ncbi.nlm.nih.gov/31319858","citation_count":22,"is_preprint":false},{"pmid":"25107909","id":"PMC_25107909","title":"Adaptor protein LRAP25 mediates myotonic dystrophy kinase-related Cdc42-binding kinase (MRCK) regulation of LIMK1 protein in lamellipodial F-actin dynamics.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25107909","citation_count":22,"is_preprint":false},{"pmid":"29319181","id":"PMC_29319181","title":"The small GTPase RhoA regulates the LIMK1/2-cofilin pathway to modulate cytoskeletal dynamics in oocyte meiosis.","date":"2018","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/29319181","citation_count":22,"is_preprint":false},{"pmid":"12123600","id":"PMC_12123600","title":"Head, neck, and spines: a role for LIMK-1 in the hippocampus.","date":"2002","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/12123600","citation_count":21,"is_preprint":false},{"pmid":"23702034","id":"PMC_23702034","title":"Identification of DAPK as a scaffold protein for the LIMK/cofilin complex in TNF-induced apoptosis.","date":"2013","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/23702034","citation_count":21,"is_preprint":false},{"pmid":"19361494","id":"PMC_19361494","title":"LIMK1 acts downstream of BMP signaling in developing retinal ganglion cell axons but not dendrites.","date":"2009","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/19361494","citation_count":20,"is_preprint":false},{"pmid":"33307230","id":"PMC_33307230","title":"Downregulation of Rac1/PAK1/LIMK1/cofilin signaling pathway in colon cancer SW620 cells treated with Chlorin e6 photodynamic therapy.","date":"2020","source":"Photodiagnosis and photodynamic therapy","url":"https://pubmed.ncbi.nlm.nih.gov/33307230","citation_count":20,"is_preprint":false},{"pmid":"22715593","id":"PMC_22715593","title":"Overexpression of LIMK1 promotes migration ability of multidrug-resistant osteosarcoma cells.","date":"2011","source":"Oncology research","url":"https://pubmed.ncbi.nlm.nih.gov/22715593","citation_count":20,"is_preprint":false},{"pmid":"33760158","id":"PMC_33760158","title":"FOXD3‑AS1/miR‑128‑3p/LIMK1 axis regulates cervical cancer progression.","date":"2021","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/33760158","citation_count":19,"is_preprint":false},{"pmid":"30833597","id":"PMC_30833597","title":"Deletion of Limk1 and Limk2 in mice does not alter cochlear development or auditory function.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/30833597","citation_count":19,"is_preprint":false},{"pmid":"27665963","id":"PMC_27665963","title":"MicroRNA-138 inhibits migration and invasion of non-small cell lung cancer cells by targeting LIMK1.","date":"2016","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/27665963","citation_count":19,"is_preprint":false},{"pmid":"32124958","id":"PMC_32124958","title":"Diallyl disulfide induces downregulation and inactivation of cofilin 1 differentiation via the Rac1/ROCK1/LIMK1 pathway in leukemia cells.","date":"2020","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/32124958","citation_count":19,"is_preprint":false},{"pmid":"33616869","id":"PMC_33616869","title":"LncRNA Rian ameliorates sevoflurane anesthesia-induced cognitive dysfunction through regulation of miR-143-3p/LIMK1 axis.","date":"2021","source":"Human cell","url":"https://pubmed.ncbi.nlm.nih.gov/33616869","citation_count":19,"is_preprint":false},{"pmid":"24642638","id":"PMC_24642638","title":"Multimodal effects of small molecule ROCK and LIMK inhibitors on mitosis, and their implication as anti-leukemia agents.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24642638","citation_count":19,"is_preprint":false},{"pmid":"32168432","id":"PMC_32168432","title":"Up-regulation of LIMK1 expression in prostate cancer is correlated with poor pathological features, lymph node metastases and biochemical recurrence.","date":"2020","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32168432","citation_count":19,"is_preprint":false},{"pmid":"28084590","id":"PMC_28084590","title":"Effects of Hippocampal LIMK Inhibition on Memory Acquisition, Consolidation, Retrieval, Reconsolidation, and Extinction.","date":"2017","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/28084590","citation_count":19,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":49403,"output_tokens":8134,"usd":0.135109,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":17782,"output_tokens":5255,"usd":0.110143,"stage2_stop_reason":"end_turn"},"total_usd":0.245252,"stage1_batch_id":"msgbatch_01BbTCMyrRPyhtEq6b1MdwCN","stage2_batch_id":"msgbatch_011dEed5bbxYvTAaQWKJevxu","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1995,\n      \"finding\": \"LIMK1 (murine Limk1) encodes a protein kinase that autophosphorylates on serine, tyrosine, and threonine residues in vitro; mutation of residue D460 within the IHRDL catalytic motif abolishes kinase activity, establishing this residue as essential for catalysis.\",\n      \"method\": \"In vitro kinase assay with GST-Limk1 fusion protein; active-site mutagenesis (D460A)\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct in vitro reconstitution of autophosphorylation plus mutagenesis of catalytic residue in a single focused study\",\n      \"pmids\": [\"7478547\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"LIMK1 (rat LIMK-1) phosphorylates serine and threonine residues of myelin basic protein in vitro, confirming serine/threonine kinase substrate activity.\",\n      \"method\": \"In vitro kinase assay with immunoprecipitated LIMK-1 and MBP as substrate\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — single lab, single in vitro assay on a non-physiological substrate\",\n      \"pmids\": [\"7651734\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"LIMK-1 knockout mice show reduced cofilin phosphorylation in vivo, abnormal dendritic spine morphology, enhanced hippocampal LTP, and deficits in spatial learning and fear responses, establishing LIMK-1 as an in vivo regulator of cofilin, spine morphogenesis, and synaptic function.\",\n      \"method\": \"LIMK-1 gene knockout mouse model; electrophysiology (LTP); behavioral tests (Morris water maze, fear conditioning); immunoblotting for p-cofilin\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean KO with multiple orthogonal readouts (biochemical, electrophysiological, behavioral), widely replicated\",\n      \"pmids\": [\"12123613\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"LIMK1 physically binds the tail domain of BMPR-II (identified by yeast two-hybrid); this interaction inhibits LIMK1's ability to phosphorylate cofilin; addition of BMP4 ligand relieves this inhibition; a BMPR-II mutant with the smallest PPH-associated C-terminal truncation fails to bind or inhibit LIMK1.\",\n      \"method\": \"Yeast two-hybrid screen; co-immunoprecipitation; in vitro cofilin phosphorylation assay; truncation mutant analysis\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — binding confirmed by Co-IP, functional consequence shown by in vitro kinase assay, mutant controls included in single rigorous study\",\n      \"pmids\": [\"12963706\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Fluid shear stress activates the Rho–ROCK–LIMK–cofilin pathway in vascular endothelial cells; dominant-negative forms of RhoA, ROCK, LIMK, and cofilin each block shear-stress-induced SREBP activation, placing LIMK downstream of ROCK and upstream of cofilin in this mechanosensing cascade.\",\n      \"method\": \"Dominant-negative mutant expression; reporter assays for SREBP activity; epistasis analysis in endothelial cells\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis with multiple dominant negatives, single lab, pathway ordering established\",\n      \"pmids\": [\"12775580\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"LIMK1 is enriched in the Golgi apparatus (requiring its LIM domain for Golgi localization) and at growth cones (requiring its PDZ domain) in neurons. Overexpression of wild-type LIMK1 suppresses trans-Golgi tubule formation and prevents Golgi fragmentation; kinase-dead LIMK1 has opposite effects. LIMK1 accelerates axon formation and regulates Golgi-derived vesicle traffic in a cofilin-phosphorylation-dependent manner.\",\n      \"method\": \"Confocal microscopy; subcellular fractionation; expression of epitope-tagged wild-type and kinase-dead LIMK1; constitutively active cofilin rescue\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization with functional consequence established by multiple constructs and rescue experiments in one study\",\n      \"pmids\": [\"15090620\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"LATS1 tumor suppressor binds LIMK1 in vitro and in vivo, co-localizes with LIMK1 at the actomyosin contractile ring during cytokinesis, and inhibits LIMK1-mediated cofilin phosphorylation; loss of LATS1 increases multinucleate cells, establishing LATS1 as a negative regulator of LIMK1 during cytokinesis.\",\n      \"method\": \"GST pull-down (in vitro binding); co-immunoprecipitation; immunofluorescence co-localization; antibody microinjection; siRNA knockdown; LATS1 knockout mice\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — in vitro binding confirmed by GST pull-down and Co-IP, functional inhibition demonstrated, genetic loss-of-function (KO mice + siRNA + antibody microinjection) with clear cytokinesis phenotype\",\n      \"pmids\": [\"15220930\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"LIMK1 binds BMPR-II in neurite tips; this interaction is required for BMP7-dependent induction of dendritic arbor in cortical neurons. The physical interaction of LIMK1 with BMPR-II synergizes with Cdc42 to activate LIMK1 catalytic activity, defining a Smad-independent BMP pathway that links the BMP receptor to actin dynamics during dendritogenesis.\",\n      \"method\": \"Co-immunoprecipitation; confocal colocalization; dominant-negative and kinase-dead constructs; cortical neuron dendrite morphology assays\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP, functional rescue, and activity assays in a single focused study establishing mechanistic pathway\",\n      \"pmids\": [\"15538389\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"B-Raf maintains actin stress fibers in fibroblasts via a ROCKII/LIMK/cofilin pathway; B-raf−/− MEFs show reduced ROCKII expression, reduced cofilin phosphorylation, and reduced F-actin; these defects are restored by overexpression of LIMK, placing LIMK downstream of ROCKII in the B-Raf pathway.\",\n      \"method\": \"B-raf knockout mouse embryonic fibroblasts; LIMK overexpression rescue; immunoblotting for p-cofilin; F-actin staining\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO cells with defined molecular phenotype and LIMK overexpression rescue, single lab\",\n      \"pmids\": [\"15199148\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Alpha2-macroglobulin (alpha2M*) binding to GRP78 on prostate cancer cells activates PAK-2 (not PAK-1), which in turn phosphorylates LIMK; silencing PAK-2 gene expression greatly attenuates LIMK phosphorylation, placing PAK-2 upstream of LIMK in this signaling cascade.\",\n      \"method\": \"siRNA gene silencing; co-immunoprecipitation; in vitro kinase assay; immunoblotting for p-LIMK and p-cofilin\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA epistasis plus co-IP and kinase assay, single lab\",\n      \"pmids\": [\"15908432\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"LIMK1 localizes to cell–cell adhesion sites in interphase, redistributes to spindle poles during prometaphase through anaphase, and accumulates at the cleavage furrow in telophase, indicating cell-cycle-dependent spatial regulation distinct from LIMK2.\",\n      \"method\": \"Immunofluorescence analysis throughout the cell cycle; nocodazole synchronization\",\n      \"journal\": \"Experimental cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — direct localization by immunofluorescence across multiple cell-cycle stages, single lab, no functional manipulation of LIMK1 localization\",\n      \"pmids\": [\"16455074\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"In prostate cancer cells, PAK4 binds LIMK1 and phosphorylates it in an HGF-dependent manner; this interaction is concentrated in peripheral foci detected by FRET-FLIM; PAK4 and LIMK1 act synergistically to increase cell migration speed via cofilin phosphorylation.\",\n      \"method\": \"Co-immunoprecipitation; in vitro phosphorylation assay; FRET-FLIM for direct intracellular interaction; siRNA knockdown; migration assays\",\n      \"journal\": \"Cellular signalling\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — direct interaction confirmed by Co-IP and independently by FRET-FLIM in living cells, functional consequence by siRNA, multiple orthogonal methods\",\n      \"pmids\": [\"18424072\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"PKA directly phosphorylates Limk1, enhancing its activity and the downstream phosphorylation of cofilin; this occurs downstream of Prkar1a loss without Rho or Rac activation, defining a Rho-independent PKA→Limk1→cofilin axis that controls cell morphology and migration.\",\n      \"method\": \"Prkar1a−/− MEFs; PKA activation by pharmacological agents; in vitro phosphorylation of Limk1 by PKA; immunoblotting; epistasis with Rho/Rac inhibitors\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct in vitro phosphorylation of Limk1 by PKA plus genetic (KO MEF) and pharmacological epistasis, single lab with multiple methods\",\n      \"pmids\": [\"19424295\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"LIMK1 physically interacts with TrkB; BDNF-induced TrkB dimerization leads to LIMK1 dimerization and transphosphorylation independent of TrkB kinase activity, activating LIMK1 which then phosphorylates cofilin and promotes actin polymerization and axonal elongation.\",\n      \"method\": \"Co-immunoprecipitation; dominant-negative TrkB constructs; cofilin phosphorylation assay; membrane fractionation; axonal elongation assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP, mechanistic mutant controls, functional readout, single lab\",\n      \"pmids\": [\"23086941\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Rho promotes a complex between fascin-1 and LIMK1/LIMK2 downstream of Rho kinase; this complex regulates filopodia stability and the interaction of fascin-1 with actin, as detected by FRET-FLIM.\",\n      \"method\": \"Co-immunoprecipitation; FRET-FLIM (fascin-1/actin interaction); Rho kinase inhibition; dominant-negative constructs\",\n      \"journal\": \"BMC biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP confirmed interaction, FRET-FLIM provides functional readout in intact cells, single lab\",\n      \"pmids\": [\"22883572\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Non-canonical BMPRII signaling through the LIMK/cofilin pathway mediates cadherin-6B-induced de-epithelialization during neural crest EMT; dominant-negative LIMK1 reduces de-epithelialization by cadherin-6B or BMP, and a phosphorylation-deficient cofilin mutant (S3A) inhibits de-epithelialization, placing LIMK1 and cofilin downstream of BMPRII in this process.\",\n      \"method\": \"Dominant-negative and wild-type LIMK1 overexpression in Xenopus neural tube; cofilin S3A mutant; in vivo delamination assay\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis with multiple dominant-negative and mutant constructs in vivo (Xenopus), single lab\",\n      \"pmids\": [\"22537493\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"DAPK functions as a scaffold protein for the LIMK/cofilin complex in TNF-induced apoptosis; TNF treatment enhances phosphorylation of LIMK at Thr508 and cofilin at Ser3; modulation of DAPK activity (inhibitor, siRNA, overexpression) correspondingly alters both phosphorylations; TNF triggers redistribution of LIMK, DAPK, and cofilin to the perinuclear compartment.\",\n      \"method\": \"Peptide array screen; siRNA knockdown; DAPK inhibitor; overexpression; immunofluorescence; immunoblotting; structural modeling\",\n      \"journal\": \"The international journal of biochemistry & cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — multiple perturbation approaches (siRNA, inhibitor, OE) with phosphorylation readouts, single lab, structural model is computational\",\n      \"pmids\": [\"23702034\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"LIMK1 interacts with adaptor LRAP25; the LRAP25-MRCK complex localizes to the lamellipodium and is required for local LIMK1 activation and cofilin phosphorylation; inhibition of MRCK or LRAP25 suppresses LIMK1 activity and disrupts lamellipodial F-actin, cell polarization, and motility.\",\n      \"method\": \"Co-immunoprecipitation; MRCK and LRAP25 siRNA knockdown; cofilin phosphorylation immunoblotting; F-actin imaging; cell migration assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP, siRNA epistasis with functional readout, single lab\",\n      \"pmids\": [\"25107909\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"LIMK1 interacts with and regulates the transcription factor CREB; LIMK1-KO mice are defective in late-phase LTP (L-LTP) and long-term memory (LTM) but not short-term memory; both L-LTP and LTM deficits are rescued by increasing CREB activity, identifying a LIMK1→CREB axis for LTM.\",\n      \"method\": \"LIMK1 knockout mice; co-immunoprecipitation (LIMK1-CREB interaction); electrophysiology (L-LTP); behavioral tests (LTM vs STM); CREB activator rescue\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — KO mice with clean phenotype, Co-IP for interaction, rescue experiment, multiple orthogonal methods\",\n      \"pmids\": [\"25645926\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"PAK6 binds LIMK1 and phosphorylates it at Thr-508, activating LIMK1 which then phosphorylates cofilin; PAK6 and LIMK1 co-localize in the cytoplasm; this PAK6→LIMK1→cofilin axis controls stress fiber formation and actin dynamics required for prostate cancer cell invasion.\",\n      \"method\": \"Co-immunoprecipitation; in vitro phosphorylation (PAK6→LIMK1 at Thr-508); cofilin phosphorylation immunoblotting; immunofluorescence co-localization; migration/invasion assays\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — Co-IP plus direct phosphorylation assay identifying specific residue, single lab\",\n      \"pmids\": [\"25714010\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"LIMK1 phosphorylates tyrosine Y573 in the cytoplasmic domain of MT1-MMP, a novel non-cofilin substrate; this phosphorylation regulates cortactin association with MT1-MMP-positive endosomes and invadopodia formation, thereby controlling matrix degradation and cell invasion.\",\n      \"method\": \"Co-immunoprecipitation; in vitro kinase assay identifying Y573 phosphorylation; site-directed mutagenesis of Y573; cortactin association assay; invadopodia/matrix degradation assays; siRNA knockdown of LIMK1/2\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct in vitro phosphorylation of a novel substrate at a defined residue, mutagenesis, functional consequence established, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"27116935\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Neuroligin-1 C-terminal domain interacts with spine-associated Rap GTPase-activating protein (SPAR) and activates LIMK1/cofilin-mediated actin reorganization to enhance spine and synapse number and modulate synaptic plasticity.\",\n      \"method\": \"Co-immunoprecipitation; dominant-negative and overexpression constructs; cofilin phosphorylation assay; spine morphology and synapse density quantification; electrophysiology\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP, functional constructs, multiple cellular readouts, single lab\",\n      \"pmids\": [\"26880202\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"ROCK2 (not ROCK1) promotes dendritic spine loss via LIMK1; ROCK2-LIMK1 pathway mediates Aβ42 oligomer-induced spine degeneration and neuronal hyperexcitability; pharmacological inhibition of LIMK1 renders dendritic spines resilient to Aβ42 and rescues spine loss in hAPP mice.\",\n      \"method\": \"Primary hippocampal neuron cultures; ROCK1/ROCK2 overexpression; LIMK1 pharmacological inhibition; live-cell microscopy; multielectrode array; hAPP mouse model with LIMK1 inhibitor treatment\",\n      \"journal\": \"Science signaling\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal approaches (cell culture, live imaging, MEA, in vivo mouse model), dissection of ROCK1 vs ROCK2 specificity, single lab with extensive validation\",\n      \"pmids\": [\"31239325\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Nischarin mutation (L972P) in edison mice activates PAK1, RAC1, and downstream LIMK1 and NF-κB signaling in middle ear epithelia, contributing to chronic otitis media, establishing LIMK1 as part of the Nischarin/PAK1/RAC1 pathway in middle ear inflammation.\",\n      \"method\": \"N-ethyl-N-nitrosourea mutagenesis mouse model; genetic interaction analysis (Nisch × Itga5); signaling pathway analysis in middle ear epithelia; immunoblotting\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic mouse model with defined mutation and pathway analysis, but LIMK1 placement is correlative within the pathway in the middle ear context\",\n      \"pmids\": [\"28806779\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"ROCK1 (not LIMK1 or PAK2) is the key non-redundant regulator of apoptotic membrane blebbing and apoptotic body formation; CRISPR/Cas9 deletion of LIMK1 does not impair apoptotic blebbing, demonstrating that LIMK1 is dispensable for this process.\",\n      \"method\": \"CRISPR/Cas9 knockout of LIMK1, ROCK1, PAK2; pharmacological inhibition; apoptotic blebbing quantification; apoptotic body formation assay\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean CRISPR KO with clear negative result for LIMK1, rigorous comparison with ROCK1 and PAK2 KOs\",\n      \"pmids\": [\"31043701\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"X-ray crystal structures of the LIMK1 kinase domain reveal a unique 'rock-and-poke' catalytic mechanism, the basis of substrate specificity, and regulation by activation loop phosphorylation; crystal structures with inhibitors PF-477736 and staurosporine provide insight into LIMK1 plasticity upon ligand binding.\",\n      \"method\": \"X-ray crystallography; RapidFire mass spectrometry activity assay; differential scanning fluorimetry; mutagenesis\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — high-resolution crystal structures with functional validation by activity assays; multiple structures in one rigorous study\",\n      \"pmids\": [\"31652302\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"LIMK1 acts downstream of BMPR-II in extending retinal ganglion cell (RGC) axons: expression of a BMPRII lacking the LIMK1-binding domain dramatically shortens axons, but manipulation of LIMK1 activity did not alter dendrite growth in the same neurons, demonstrating compartment-specific LIMK1 regulation by BMPRII.\",\n      \"method\": \"In vivo Xenopus RGC experiments; wild-type and kinase-dead LIMK1 expression; BMPRII truncation mutant expression; axon and dendrite length quantification\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo genetic epistasis in Xenopus with multiple constructs, single lab\",\n      \"pmids\": [\"19361494\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Delta opioid receptor and ORL1 receptor agonists activate cofilin through a ROCK–LIMK–β-arrestin-1 pathway to regulate actin polymerization; this controls receptor function (inhibition of voltage-dependent Ca2+ channels in DRG neurons); behavioral effects of these agonists are enhanced in β-arrestin-1 knockout mice or prevented by ROCK inhibition.\",\n      \"method\": \"DRG neuron electrophysiology; β-arrestin-1 knockout mice; ROCK inhibitor (Y-27632); cofilin activation assay; behavioral assays\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic (KO mice) and pharmacological epistasis with functional electrophysiological and behavioral readouts, single lab\",\n      \"pmids\": [\"24239352\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"LIMK-dependent actin polymerization in DRG primary sensory neurons promotes inflammatory heat hyperalgesia; inflammatory stimuli increase LIMK activity and cofilin phosphorylation in DRG; LIMK knockdown or prevention of cofilin phosphorylation attenuates hyperalgesia and blocks inflammatory enhancement of TRPV1 response and serine phosphorylation of TRPV1.\",\n      \"method\": \"In vivo rat CFA model; LIMK knockdown; cofilin phosphorylation assay; actin polymerization assay; TRPV1 electrophysiology; behavioral pain assays\",\n      \"journal\": \"Science signaling\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo model with LIMK knockdown, multiple orthogonal mechanistic readouts (kinase activity, actin polymerization, TRPV1 function, behavior), single lab with comprehensive mechanistic follow-up\",\n      \"pmids\": [\"24962708\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"RhoA regulates the LIMK1/2-cofilin pathway during mouse oocyte meiosis: ROCK inhibition decreases p-LIMK1/2 and p-cofilin; LIMK1/2 disruption impairs spindle migration, polar body extrusion, and actin filament distribution; the pathway is ordered as RhoA→ROCK→LIMK1/2→cofilin.\",\n      \"method\": \"Mouse oocyte live-cell imaging; LIMK1/LIMK2 knockdown; ROCK inhibition; RhoA inhibition; cofilin phosphorylation immunoblotting; spindle morphology analysis\",\n      \"journal\": \"Journal of cellular physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic (KD) and pharmacological epistasis in a defined cellular system with multiple functional readouts, single lab\",\n      \"pmids\": [\"29319181\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"LIMK1 mRNA stability is increased when the m6A reader YTHDC2 is downregulated, because YTHDC2 normally recognizes the GGACA m6A site on LIMK1 mRNA and promotes its degradation; elevated LIMK1 then facilitates eIF2α phosphorylation, ER stress, and stress granule formation, causing 5-FU chemoresistance.\",\n      \"method\": \"YTHDC2 siRNA knockdown; m6A site mutation; LIMK1 mRNA stability assay; eIF2α phosphorylation immunoblotting; stress granule immunofluorescence; 5-FU sensitivity assays\",\n      \"journal\": \"Cancer letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — m6A reader-mRNA mechanism with mutational validation and functional downstream readouts, single lab\",\n      \"pmids\": [\"37778684\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"High NRG1 expression activates LIMK1 and increases cofilin phosphorylation in postsynaptic densities; inhibiting LIMK1 or blocking the NRG1-LIMK1 interaction rescues spine density reduction in ctoNrg1 mice overexpressing neuregulin-1.\",\n      \"method\": \"NRG1-overexpressing transgenic mice; LIMK1 inhibitor treatment; NRG1-LIMK1 interaction blocking; immunoblotting for p-cofilin; spine density quantification; mEPSC electrophysiology\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo transgenic model with pharmacological rescue and interaction blocking, multiple readouts, single lab\",\n      \"pmids\": [\"33854034\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"LIMK1 is a serine/threonine (and tyrosine) kinase whose principal substrate is cofilin, which it phosphorylates at Ser3 to inactivate this actin-depolymerizing factor and thereby stabilize F-actin; LIMK1 activity is controlled by upstream kinases (ROCK1/2, PAK1/2/4/6, PAK4 via MRCK-LRAP25, and PKA) that phosphorylate its activation loop, and is modulated by direct binding partners including BMPR-II (which inhibits then releases LIMK1 in response to BMP ligand), LATS1 (which inhibits LIMK1 during cytokinesis), TrkB (which activates LIMK1 via dimerization/transphosphorylation), DAPK (which scaffolds the LIMK/cofilin complex during TNF-induced apoptosis), and fascin-1; LIMK1 localizes to the Golgi (via its LIM domain), growth cones (via its PDZ domain), and spindle poles/cleavage furrow during mitosis; beyond cofilin, LIMK1 also phosphorylates tyrosine Y573 of MT1-MMP to regulate invadopodia and matrix degradation, and interacts with the transcription factor CREB to support long-term memory; in vivo, LIMK1 is essential for dendritic spine morphogenesis, hippocampal LTP, long-term memory formation, cortical neuronal progenitor proliferation and migration, and inflammatory pain sensitization via TRPV1 regulation.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"LIMK1 is a serine/threonine protein kinase that links upstream Rho-family signaling to actin cytoskeletal remodeling by phosphorylating the actin-depolymerizing factor cofilin at Ser3, thereby stabilizing F-actin [#2, #4]. Its catalytic activity depends on the conserved IHRDL active-site residue D460, and the enzyme autophosphorylates on serine, threonine, and tyrosine [#0]; crystal structures of the kinase domain define its 'rock-and-poke' catalytic mechanism, substrate specificity, and dependence on activation-loop phosphorylation [#25]. LIMK1 is engaged downstream of ROCK in mechanosensing and stress-fiber maintenance [#4, #8], and is activated by multiple upstream kinases through phosphorylation of its activation loop (Thr508), including PAK2, PAK4, PAK6, and PKA [#9, #11, #12, #19]. Its output is locally controlled by direct binding partners: BMPR-II binds and inhibits LIMK1 until BMP ligand relieves the block and Cdc42 synergizes to activate it during dendritogenesis and axon extension [#3, #7, #26]; LATS1 inhibits LIMK1 at the contractile ring during cytokinesis [#6]; TrkB drives BDNF-dependent LIMK1 dimerization and transphosphorylation [#13]; and adaptors such as LRAP25-MRCK confine LIMK1 activation to the lamellipodium [#17]. LIMK1 localizes to the Golgi via its LIM domain and to growth cones via its PDZ domain, where it regulates vesicle traffic and axon formation [#5], and it shows cell-cycle-dependent redistribution to spindle poles and the cleavage furrow [#10]. Beyond cofilin, LIMK1 phosphorylates Tyr573 of MT1-MMP to regulate invadopodia and matrix degradation [#20]. In vivo, LIMK1 controls dendritic spine morphology, hippocampal LTP, and—via interaction with CREB—late-phase LTP and long-term memory [#2, #18], and LIMK-dependent actin remodeling in sensory neurons drives inflammatory heat hyperalgesia through TRPV1 [#28]. ROCK2-LIMK1 signaling mediates Aβ42-induced dendritic spine degeneration, and LIMK1 inhibition rescues spine loss in an Alzheimer's disease mouse model [#22].\",\n  \"teleology\": [\n    {\n      \"year\": 1995,\n      \"claim\": \"Established that LIMK1 is a catalytically active protein kinase and identified the active-site residue required for activity, defining its enzymatic identity.\",\n      \"evidence\": \"In vitro kinase/autophosphorylation assays with GST-Limk1 and D460A active-site mutagenesis; MBP substrate phosphorylation\",\n      \"pmids\": [\"7478547\", \"7651734\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological substrate not yet identified\", \"No structural basis for catalysis\", \"Upstream activators unknown\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Defined cofilin as the in vivo LIMK1 substrate and connected the kinase to spine morphogenesis and synaptic plasticity, moving LIMK1 from a biochemical activity to a physiological regulator of the actin cytoskeleton.\",\n      \"evidence\": \"LIMK1 knockout mice with p-cofilin immunoblotting, LTP electrophysiology, and learning/memory behavioral tests\",\n      \"pmids\": [\"12123613\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Upstream activating signals in neurons not resolved\", \"Direct CREB/transcriptional link not yet established\", \"Mechanism of spine actin regulation not fully defined\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Identified BMPR-II as a direct binding partner that inhibits LIMK1 until BMP ligand relieves the block, establishing a ligand-gated mode of LIMK1 regulation and a Smad-independent BMP pathway.\",\n      \"evidence\": \"Yeast two-hybrid, Co-IP, in vitro cofilin phosphorylation, and PPH-associated truncation mutant analysis\",\n      \"pmids\": [\"12963706\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of inhibition not defined\", \"How ligand binding relieves inhibition mechanistically unclear\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Placed LIMK1 within the Rho-ROCK-cofilin mechanosensing cascade, ordering it downstream of ROCK and upstream of cofilin.\",\n      \"evidence\": \"Dominant-negative epistasis (RhoA, ROCK, LIMK, cofilin) with SREBP reporter assays in endothelial cells\",\n      \"pmids\": [\"12775580\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct ROCK phosphorylation of LIMK1 not shown here\", \"Restricted to a single signaling output (SREBP)\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Resolved LIMK1 subcellular targeting and demonstrated domain-specific localization with functional consequences for Golgi traffic and axon formation.\",\n      \"evidence\": \"Confocal microscopy, fractionation, wild-type vs kinase-dead constructs, and constitutively active cofilin rescue\",\n      \"pmids\": [\"15090620\", \"16455074\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"LIM-domain Golgi anchor partner not identified\", \"Functional role of spindle-pole/cleavage-furrow localization not tested\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Identified LATS1 and BMPR-II/Cdc42 as context-specific regulators, showing LIMK1 is negatively controlled during cytokinesis and positively activated during dendritogenesis.\",\n      \"evidence\": \"GST pull-down, Co-IP, immunofluorescence, antibody microinjection, siRNA, and KO mice (LATS1); reciprocal Co-IP and dendrite assays (BMPR-II/Cdc42)\",\n      \"pmids\": [\"15220930\", \"15538389\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which LATS1 inhibits the kinase unresolved\", \"How Cdc42 synergizes with BMPR-II binding not structurally defined\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Mapped multiple PAK-family kinases as direct upstream activators that phosphorylate LIMK1's activation loop, establishing PAK→LIMK1→cofilin as a recurring motility axis.\",\n      \"evidence\": \"siRNA epistasis, Co-IP, FRET-FLIM, in vitro phosphorylation (including Thr508 mapping), and migration/invasion assays across PAK2, PAK4, PAK6\",\n      \"pmids\": [\"15908432\", \"18424072\", \"25714010\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Selectivity among PAK isoforms in different tissues not resolved\", \"Quantitative contribution of each PAK to activation-loop phosphorylation unclear\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Demonstrated a Rho-independent route to LIMK1 activation via direct PKA phosphorylation, broadening the upstream input map beyond Rho-GTPase signaling.\",\n      \"evidence\": \"Prkar1a-/- MEFs, pharmacological PKA activation, in vitro phosphorylation of Limk1 by PKA, and Rho/Rac inhibitor epistasis\",\n      \"pmids\": [\"19424295\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"PKA target residue on LIMK1 not defined\", \"Crosstalk with Rho-driven activation not characterized\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Expanded LIMK1 regulation to receptor- and scaffold-driven mechanisms—TrkB-induced dimerization/transphosphorylation, fascin-1 complex formation, and LRAP25-MRCK localized activation.\",\n      \"evidence\": \"Reciprocal Co-IP, FRET-FLIM, dominant-negative constructs, and functional actin/migration readouts\",\n      \"pmids\": [\"23086941\", \"22883572\", \"25107909\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Stoichiometry of LIMK1 dimers not defined\", \"Direct vs indirect nature of some interactions not fully validated\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Identified DAPK as a scaffold for the LIMK/cofilin complex in TNF-induced apoptosis, linking LIMK1 to programmed cell death signaling.\",\n      \"evidence\": \"Peptide array, siRNA, DAPK inhibitor and overexpression, phospho-immunoblotting (LIMK Thr508, cofilin Ser3), and immunofluorescence\",\n      \"pmids\": [\"23702034\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether DAPK directly phosphorylates LIMK1 not established\", \"Structural model is computational\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Established a LIMK1→CREB axis required selectively for late-phase LTP and long-term memory, revealing a transcriptional output distinct from acute actin regulation.\",\n      \"evidence\": \"LIMK1 KO mice, Co-IP for LIMK1-CREB interaction, L-LTP electrophysiology, memory testing, and CREB-activator rescue\",\n      \"pmids\": [\"25645926\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which LIMK1 regulates CREB activity unresolved\", \"Whether kinase activity is required for the CREB effect not defined\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Identified MT1-MMP Tyr573 as a non-cofilin LIMK1 substrate, demonstrating that LIMK1 directly regulates invadopodia and matrix degradation beyond actin filament dynamics.\",\n      \"evidence\": \"Co-IP, in vitro kinase assay mapping Y573, Y573 mutagenesis, cortactin association, and invadopodia/matrix degradation assays\",\n      \"pmids\": [\"27116935\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full repertoire of non-cofilin substrates unknown\", \"Tyrosine kinase activity scope not broadly characterized\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Demonstrated disease-relevant LIMK1 functions—ROCK2-LIMK1 mediating Aβ42-induced spine degeneration with inhibitor rescue—while delineating where LIMK1 is dispensable (apoptotic blebbing) and solving the kinase-domain structure.\",\n      \"evidence\": \"Hippocampal cultures, ROCK1/2 dissection, LIMK1 inhibitor in hAPP mice (spine loss); CRISPR LIMK1 KO negative result for blebbing; X-ray crystallography with inhibitors\",\n      \"pmids\": [\"31239325\", \"31043701\", \"31652302\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo selectivity of LIMK1 inhibitors not fully addressed\", \"Structural basis for partner-mediated regulation not captured in isolated kinase-domain structures\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Established LIMK1-dependent actin remodeling as a driver of inflammatory pain via TRPV1 regulation, linking the kinase to nociceptor sensitization.\",\n      \"evidence\": \"In vivo CFA rat model, LIMK knockdown, cofilin phosphorylation and actin polymerization assays, and TRPV1 electrophysiology/behavior\",\n      \"pmids\": [\"24962708\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism connecting actin polymerization to TRPV1 phosphorylation not fully defined\", \"Whether LIMK1 acts on TRPV1 directly not established\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Identified post-transcriptional control of LIMK1 by m6A reader YTHDC2, linking LIMK1 abundance to ER stress and chemoresistance.\",\n      \"evidence\": \"YTHDC2 siRNA, m6A site mutation, mRNA stability assay, eIF2α phospho-immunoblotting, and 5-FU sensitivity assays\",\n      \"pmids\": [\"37778684\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Generality of LIMK1 m6A regulation across tissues unknown\", \"Mechanism by which LIMK1 promotes eIF2α phosphorylation unclear\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How LIMK1's diverse upstream inputs (Rho-ROCK, PAK isoforms, PKA, receptor-driven dimerization) and binding-partner-imposed inhibition are integrated to produce substrate- and compartment-specific outputs remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified structural model of partner-regulated activation\", \"Full substrate repertoire beyond cofilin and MT1-MMP undefined\", \"Quantitative logic of input integration not established\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 2, 3, 20, 25]},\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [0, 1, 20]},\n      {\"term_id\": \"GO:0008092\", \"supporting_discovery_ids\": [2, 14]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [5]},\n      {\"term_id\": \"GO:0005856\", \"supporting_discovery_ids\": [5, 8, 17]},\n      {\"term_id\": \"GO:0005815\", \"supporting_discovery_ids\": [10]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [19]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [3, 4, 7, 12, 13]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [2, 18, 21, 22, 28]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [6, 10, 29]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [7, 15, 26]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"CFL1\", \"BMPR2\", \"LATS1\", \"PAK4\", \"PAK6\", \"NTRK2\", \"MMP14\", \"FSCN1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}